Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35047Full metadata record
| ???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
|---|---|---|
| dc.contributor.advisor | 江東亮 | |
| dc.contributor.author | Guei-Jen Shieh | en |
| dc.contributor.author | 謝桂貞 | zh_TW |
| dc.date.accessioned | 2021-06-13T06:39:36Z | - |
| dc.date.available | 2005-08-04 | |
| dc.date.copyright | 2005-08-04 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-08-03 | |
| dc.identifier.citation | 一、中文部分
呂克桓：氣喘病之流行病學。1995；31-34。 林瑞雄、戴東元、謝貴雄、陸坤泰、李龍騰、賴美淑、陳建仁、王榮德、林嘉明、羅俊男、蕭朱杏、陳建煒、邱淑媞、黃國晉、宋鴻樟、何文照、邱文達、陳麗美、黃松元、周碧瑟、彭瑞鵬、蕭光明、劉文良、郭旭崧、賴俊雄、郭憲文、李孟智、黃國恩、郭育良、蘇慧貞、葛應欽、李明亮、蕭正光：學童呼吸系統健康檢查計劃。行政院環境保護署研究計畫EPA-85-1601-08，1996。 吳清平：氣喘的分類。國防醫學2000；31（4）：265-271。 氣喘診療指引：行政院衛生署中華民國八十九年編撰。 彭殿王：氣喘的藥物治療。臨床醫學2002；50（5）：308-311。 吳家興、林瑞雄、謝貴雄、邱文達、陳麗美、邱淑媞、黃國晉、劉文良、邱宏毅、蕭慧娟、方淑慧、陳雄文、林嘉明、宋鴻樟：台灣北部國中學生氣喘盛行率調查。中華衛誌1998；17：214-225。 二、英文部分 Adams RJ, Fuhlbrigge A, Finkelstein JA, Lozano P, Livingston JM, Weiss KB, Weiss ST. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001;107:706-711. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002;110(2 Pt 1):315-322. Allen DH, Delohery J, Baker G. Monosodium L-glutamate-induced asthma. J Allergy Clin Immunol 1987;80:530-537. American Thoracic Society Committee on Diagnostic Standards. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 1962;85:762-768. Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Pare P. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001;164:625-631. Anja A, Verberne PH, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF, and the Dutch Pediatric Asthma Study Group. One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997;156:688-695. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of two years. Clin Exp Allergy 1993;23:504-511. Barnes PJ. Current therapies for asthma. Promise and limitations. Chest 1997;111:S17-S26. Bauman A, Mitchell CA, Henry RL, Robertson CF, Abramson MJ, Comino EJ, Hensley MJ, Leeder SR. Asthma morbidity in Australia: an epidemiological study. Med J Aust 1992;156:827-831. Beimfohr C, Maziak W, von Mutius E, Hense HW, Leupold W, Hirsch T, Keil U, Weiland SK. The use of anti-asthmatic drugs in children: results of a community-based survey in Germany. Pharmacoepidemiol Drug Saf 2001;10:315-321. Bjorksten B. The environmental influence on childhood asthma. Allergy 1999;54:17-23. Blais L, Ernst P, Boivin JF, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998;158: 126-132. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998;113:587-592. Braunwald E, Fanci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine, 2001;vol.1:187-193. Breslin ABX. New developments in anti-asthma drugs. Med J Aust 1993;158:779-782. British Thoracic Society and others. Guidelines for the management of asthma: a summary. BMJ. 1993;306:776-782. Camden and Islington Family Health Services Authority and Health Authority. Asthma in your practice: morbidity, prescribing and hospital admissions. In: Health needs assessment and your general practice. London: Camden and Islington FHSA and HA, 1995. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health 1992;82:59-65. Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with cost and variation in prescribing among GPs. Fam Pract 2000;17: 36-41. Centers for Disease Control and Prevention (CDC). Asthma prevalence and control characteristics by race/ethnicity--United States, 2002. MMWR Morb Mortal Wkly Rep 2004;53:145-148. Chafee FH, Settipane GA. Asthma caused by FD&C approved dyes. J Allergy 1967;40:65-72. Chen P, Yu R, Hou X, Tan P, Xie H, Kong L, Li Y, Yu R, Li S, Wu Z, Chai W, Wang Y, Wang L, Zhao L. Epidemiological survey on bronchial asthma in Liaoning province. Zhonghua Jie He He Hu Xi Za Zhi 2002;25:603-606. Chen CY, Chiu HF, Yeh MK, Chang CC, Yang CY. The use of anti-asthmatic medications among pediatric patients in Taiwan. Pharmacoepidemiol Drug Saf 2003a;12:129-133. Chen CY, Chiu HF, Yeh MK, Yang CY. Use of anti-asthmatic medications in elderly Taiwanese patients. Kaohsiung J Med Sci 2003b;19:305-312. Chhabra SK, Pandey KK. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. J Asthma 2002;39:375-381. Chilmonczyk BA, Salmun LM, Megathlin KN, Neveux LM, Palomaki GE, Knight GJ, Pulkkinen AJ, Haddow JE. Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med 1993;328:1665-1669. Ciba Foundation Guest Symposium. Terminology definition, classification of chronic pulmonary emphysema and related conditions. Thorax 1959;14:286-299. Comis A, Valletta EA, Sette L, Andreoli A, Boner AL. Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children. Eur Respir J 1993;6:523-526. Crane J, Burgess C, Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbuatomol, fenoterol, and isoprenaline. Thorax 1989;44:136-140. Craps L. Ketotifen in the oral prophylaxis of bronchial asthma: a review. Pharmatherapeutica 1981;3:18-35. Department of Health and Human Services (DHHS). International Consensus Report on Diagnosis and Treatment of Asthma. Washington DC: DHHS 1992. Diette GB, Wu AW, Skinner EA, Markson L, Clark RD, McDonald RC, Healy JP Jr, Huber M, Steinwachs DM. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids. Arch Intern Med 1999;159:2697-2704. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277: 887-891. Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, Huiart L; Reseau de Recherche Clinique en Pneumonologie Pediatrique. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy. 2001;56:944-948. Eisner MD, Lieu TA, Chi F, Capra AM, Mendoza GR, Selby JV, Blanc PD. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J 2001;17:233-40. Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B, Horwitz RI, Boivin JF, McNutt M, Buist AS. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268:3462-3464. Evans D, Levison MJ, Feldman CH, Clark NM, Wasilewski Y, Levin B, Mellins RB. The impact of passive smoking on emergency room visits of urban children with asthma. Am Rev Respir Dis 1987;135:567-572. Evans R, Mullally DI, Wilson RW, Gergen PJ, Rosenberg HM, Grauman JS, Chevarley FM, Feinleib M. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965-1984. Chest 1987;91(S6):65S-74S. Falliers CJ. Acetaminophen and aspirin challenges in subgroups of asthmatics. J Asthma 1983;20:39-49. Ferreira MA. Inflammation in allergic asthma: Initiating events, immunological response and risk factors. Respirology. 2004;9:16-24. Folkert G, Busse WM, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998;157:1708-1720. Freedman BJ. Asthma induced by sulphur dioxide, benzoate and tartrazine contained in orange drinks. Clin Allergy 1977;7:407-415. Garcia-Marcos L, Schuster A, Perez-Yarza EG. Benefit-risk assessment of antileukotrienes in the management of asthma. Drug Saf 2003;26:483-518. Gerdtham UG, Johannesson M, Jonsson B. Drug expenditure and new drug introductions: the Swedish experience. Pharmacoeconomics 1993;4:215-225. Gerdtham UG, Hertzman P, Jonsson B, Boman G. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991. Med Care 1996;34:1188-1198. Glaxo Wellcome Inc. Asthma in America, National Survey. Washington DC, 1998. Global Initiative for Asthma. 2002. Global strategy for asthma management and prevention. National, Heart, Lung, and Blood Institute. National Institute of Health. Goodman DC, Lozano P, Stukel TA, Chang Ch, Hecht J. Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics 1999;104(2 Pt 1):187-194. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest 1995;108:28-35. Griffiths C, Naish J, Sturdy P, Pereira F. Prescribing and hospital admissions for asthma in east London. BMJ 1996;312:481-482. Gross NJ. Ipratropium bromide. N Engl J Med 1988;319:486-494. Halfon N, Newacheck PW. Trends in the hospitalization for acute childhood asthma, 1970-84. Am J Public Health 1986;76:1308-1311. Hanania NA, David-Wang A, Kesten S, Chapman KR. Factors associated with emergency department dependence of patients with asthma. Chest 1997;111:290-295. Hanson B, McGue M, Roitman-Johnson B, Segal NL, Bouchard TJ Jr, Blumenthal MN. Atopic disease and immunoglobulin E in twins reared apart and together. Am J Hum Genet 1991;48:873-879. Hay IF, Higenbottam TW. Has the management of asthma improved? Lancet 1987;2:609-611. Hong SP, Park HS, Lee MK, Hong CS. Oral provocation tests with aspirin and food additives in asthmatic patients. Yonsei Med J 1989;30:339-345. Horn CR, Cochrane GM. Management of asthma in general practice. Respir Med 1989;83:67-70. Hsieh KH, Shen JJ. Prevalence of childhood asthma in Taipei, Taiwan, and other asian pacific countries. J Ashtma 1988;25:73-82. Huang D, O’Brien RG, Harman E, Aull L, Reents S, Visser J, Shieh G, Hendeles L. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med 1993;119:1155- 1160. Huang S-L, Pan W-H. Dietary fats and asthma in teenagers: analyses of the first nutrition and health survey in Taiwan (NAHSIT). Clin Exp Allergy 2001;31:1875-1880. Huang SL, Tsai PF, Yeh YF. Negative association of Enterobius infestation with asthma and rhinitis in primary school children in Taipei. Clin Exp Allergy 2002;32:1029-1032. Huovinen E, Kaprio J, Laitinen LA, Koskenvuo M. Social predictors of adult asthma: a co-twin case-control study. Thorax. 2001;56:234-236. Iikura Y, Hashimoto K, Akasawa A, Katsunuma T, Ebisawa M, Saito H, Sakaguchi N, Matsumoto K, Nonomura K, Soda A, Koya N. Serum theophylline concentration levels and preventative effects on exercise-induced asthma. Clin Exp Allergy 1996;26 Suppl 2:38-41. Jackson R, Sears MR, Beaglehole R, Rea HH. International trends in asthma mortality-1970 to 1985. Chest 1988;94:914-918. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434-440. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O’Toole S, Myint SH, Tyrrell DAJ, Holgate ST. Community study of role of virus infections in exacerbations of asthma in 9–11 year old children. BMJ 1995;310:1225-1229. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83. Kaufman HS, Frick OL. The development of allergy in infants of allergic parents: a prospective study concerning the role of heredity. Ann Allergy 1976;37:410-415. Kelly HW, Murphy S. Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother 1992;26:81-91. Kolbe J, Vamos M, Fergusson W. Socio-economic disadvantage, quality of medical care and admission for acute severe asthma. Aust N Z J Med. 1997;27: 294-300. Kuo S-H. Implementation of asthma guideline in Taiwan – The management in medical centers. J Asthma 2002;39:767-770. Labrecque M, Laurier C, Champagne F, Kennedy W, Pare M, Cartier A. Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma. J Asthma 2003;40:829-835. Lal S, Dorow PD, Venho KK, Chatterjee SS. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease. Chest 1993;104:438-447. Lagerlov P, Hjortdahl P, Saxegaard L, Andrew M, Matheson I. Structuring prescribing data into traffic-light categories; a tool for evaluating treatment quality in primary care. Fam Pract 2001;18:528-533. Lang DM, Sherman MS, Polansky M. Guidelines and realities of asthma management. The Philadelphia story. Arch Intern Med 1997 ;157:1193-1200. Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics. Am Rev Respir Dis 1977;116:861-869. Laumann JM, Bjornson DC. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-base drug utilization review methodology. Ann Pharmacother 1998;32:1290-1294. Leeman BJ, Cabrera MR. No association found between Strongyloides infestation and asthma. J Asthma 1995;32:57-62. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-152. Lichtenstein P, Svartengren M. Genes, environments, and sex: factors of importance in atopic diseases in 7-9-year-old Swedish twins. Allergy 1997;52:1079-1086. Lin RS, Sung FC, Huang SL, Gou YL, Ko YC, Gou HW, Shaw CK. Role of urbanization and air pollution in adolescent asthma: a mass screening in Taiwan. J Formos Med Assoc 2001;100:649-655. Lipworth BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 1989;140:586-592. Lofdahl CG, Svedmyr N. Beta-agonists – friends or foes. Eur Respir J 1991;4:1161-1165. Lofdahl CG, Svedmyr N. Beta-agonists – still more friends than foes. Eur Respir J 1992;5:898-900. Lulich KM, Paterson JW, Goldie RG. Ipratropium, sodium cromoglycate and antihistamines. Med J Aust 1995;162:157-159. Magnussen H, Reuss G, Jorres R. Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentration and in a dose-dependent fashion. J Allergy Clin Immunol 1988;81:531-537. Medici TC, Radielovic P, Morley J. Ketotifen in the prophylaxis of extrinsic bronchial asthma. A multicenter controlled double-blind study with a modified-release formulation. Chest 1989;96:1252-1257. Miyamoto T. Epidemiology of pollution-induced airway disease in Japan. Allergy 1997;52:30-34. Morton AR, Ogle SL, Fitch KD. Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma. Ann Allergy 1992;68:143-148. Nafstad P, Nystad W, Magnus P, Jaakkola JJ. Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma 2003;40:343-348. Naish J, Sturdy P, Toon P. Appropriate prescribing in asthma and its related cost in east London. BMJ 1995;310:97-100. Nathan RA, Kemp JP; Antileukotriene Working Group. Efficacy of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol. 2001;86(6 Suppl 1):9-17. Neville RG, Clark RC, Hoskins G, Smith B. National asthma attack audit 1991-2. BMJ 1993;306:559-562. Newman-Taylor A. Environmental determinants of asthma. Lancet 1995;346:129-130. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993;307:982-986. Ng TP, Niti M, Tan WC. Trends and ethnic differences in asthma hospitalization rates in Singapore, 1991 to 1998. Ann Allergy Asthma Immunol 2003;90:51-55. van Nickerk CH, Weinberg EG, Shore SC, de V Heese H, van Schalkwyk DJ. Prevalence of asthma: a comparative study of urban and rural Xhosa children. Clin Allergy 1979;9:319-324. Nilsson L, Castor O, Lofman O, Magnusson A, Kjellman NI. Allergic disease in teenagers in relation to urban or rural residence at various stages of childhood. Allergy 1999;54:716-721. Nishi K, Fujimura M, Myou S, Ooka T, Sakamoto S, Saitou M, Kasahara K, Matsuda T. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma. Clin Auton Res 1993;3:41-44. Novembre E, Frongia GF, Veneruso G, Vierucci A. Inhibition of exercise-induced-asthma (EIA) by nedocromil sodium and sodium cromoglycate in children. Pediatr Allergy Immunol 1994;5:107-110. Ownby DR. Environmental factors versus genetic determinants of childhood inhalant allergies. J Allergy Clin Immunol 1990;86:279-287. Persky VW, Slezak J, Contreras A, Becker L, Hernandez E, Ramakrishnan V, Piorkowski J. Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children. Ann Allergy Asthma Immunol 1998;81:266-271. Pierson WE, Koenig JQ. Respiratory effects of air pollution on allergic disease. J Allergy Clin Immunol 1992;90:557-566. Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A. Salmeterol versus theophylline in the treatment of asthma. Ann Allergy Asthma Immunol 1997;78:457-64. Pollart SM, Smith TF, Morris EC, Gelber LE, Platts-Mills TA, Chapman MD. Environmental exposure to cockroach allergens: analysis with monoclonal antibody-based enzyme immunoassays. J Allergy Clin Immunol 1991;87:505-510. Roberts G, Lack G. Food allergy and asthma--what is the link? Paediatr Respir Rev 2003;4:205-212. Roberts SJ, Baumer JH, Currie CJ, Evans M, Morgan CL, Griffiths C, Sturdy P, Naish J, Feder G, Omar R, Dolan S, Pereira F, Shelley M, Croft P, Pantin C, Chapman S. Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. BMJ 1997;314:680-682. Robuschi M, Gambaro G, Sestini P, Pieroni MG, Refini RM, Vaghi A, Bianco S. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. Am J Respir Crit Care Med 1997;155:1461-1464. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part I. Am Rev Respir Dis 1987;136:1486-1508. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983. Schwartz HJ, Blumenthal M, Brady R, Braun S, Lockey R, Myers D, Mansfield L, Mullarkey M, Owens G, Ratner P, Repsher L, van As A. A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment? Chest 1996;109:945-952. Sears MR. Changing patterns in asthma morbidity and mortality. J Invest Allergol Clin Immunol 1995;5:66-72. Sears MR, Taylor DR, Print CG, Lake DC, Herbison GP, Flannery EM. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma. Chest 1992;102:1709-1715. Shelly M, Croft P, Chapman S, Pantin C. Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. BMJ 1996;313:1124-1126. Shelly M, Croft P, Chapman S, Pantin C. Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? J Clin Epidemiol 2000;53:1217-1221. Sherrill DL, Martinez FD, Lebowitz MD, Holdaway MD, Flannery EM, Herbison GP, Stanton WR, Silva PA, Sears MR. Longitudinal effects of passive smoking on pulmonary function in New Zealand children. Am Rev Respir Dis 1992;145:1136-1141. Shields AE, Comstock C, Weiss KB. Variations in asthma care by race/ethnicity among children enrolled in a state Medicaid program. Pediatrics 2004;113(3 Pt 1):496-504. Shireman TI, Heaton PC, Gay WE, Cluxton RJ, Moomaw CJ. Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 2002;36:557-564. Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997;79:333-338. Sin DD and Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001;119:720-725. Sin DD, Man SF. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 2002;162:1591-1595. Skobeloff EM, Spivey WH, St Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992;268:3437-3440. Sole D, Yamada E, Vana AT, Costa-Carvalho BT, Naspitz CK. Prevalence of asthma and related symptoms in school-age children in Sao Paulo, Brazil. Unternational Study of Asthma and Allergies in Children (ISSAC). J Asthma 1999;205-212. Spector SL, Antileukotriene Working Group. Safety of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol 2001;86(6 suppl 1):18-23. Spector SL, Surette ME. Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma? Ann Allergy Asthma Immunol 2003;90:371-7; quiz 377-8, 421. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-506. Stempel DA, Busse WW. Inhaled corticosteroids-first-line preventive therapy in asthma. Evidence from the current medical literature. J Allergy Clin Immunol 1998;102:S1-S3. Strauss RE, Wertheim DL, Bonagura VR, Valacer DJ. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics 1994;93:205-210. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J 1994;7:1602-1609. Suissa S, Dennis R, Ernst P, Sheehy O, Wood-Dauphinee S. Effectiveness of the leukotriene receptor antagonist Zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126:177-183. Sunyer J, Anto JM, Castellsague J, Soriano JB, Roca J. Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. Eur Respir J 1996;9:1880-1884. Svanes C, Omenaas E, Heuch JM, Irgens LM, Gulsvik A. Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. Eur Respir J 1998;12:1366- 1370. Swanson MC, Agarwal MK, Reed CE. An immunochemical approach to indoor aeroallergen quantitation with a new volumetric air sampler: studies with mite, roach, cat, mouse, and guinea pig antigens. J Allergy Clin Immunol 1985;76:724-729. Targonski PV, Persky VW, Kelleher P, Addington W. Characteristics of hospitalization for asthma among persons less than 35 years of age in Chicago. J Asthma 1995;32:365-372. Teramoto S, Matsuse T, Fukuchi Y. Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis. Am J Med 2001; 110:243-244. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232. Thoracic Society, R.O.C. Guidelines for diagnosis and management of asthma in adults. Thorac Med 1995;10 (Suppl):S1-S38. Tovey ER, Chapman MD, Platts-Mills TA. Mite faeces are a major source of house dust allergens. Nature 1981;289(5798):592-593. Towns SJ, Mellis CM. Role of acetyl salicylic acid and sodium metabisulfite in chronic childhood asthma. Pediatrics 1984;73:617-631. Tsai JJ, Chan SC, Ho CK, Su YC, Feng TC. Efficacy of zafirlukast in the treatment of patients with bronchial asthma. J Microbiol Immunol Infect 2001;34:63-70. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981;36:523-529. Ushiyama Y, Matsumoto K, Shinohara M, Wakiguchi H, Sakai K, Komatsu T, Yamamoto S. Nutrition during pregnancy may be associated with allergic diseases in infants. J Nutr Sci Vitaminol (Tokyo) 2002;48: 345-351. Wan K-S, Chen L-H, Lin Y-L. Evaluation of the consensus of the national asthma treatment guidelines in Taiwan. Acta Paediatr Tw 2002;43:140-143. Warner JO. Review of prescribed treatment for children with asthma in 1990. BMJ 1995;311:663-666. Watson JP, Cowen P, Lewis RA. The relationship between asthma admission rates, routes of admission, and socioeconomic deprivation. Eur Respir J 1996;9:2087-2093. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med 1996;334:1380-1388. Weiss ST, Tager IB, Speizer FE, Rosner B. Persistent wheeze: its relation to respiratory illness, cigarette smoking, and level of pulmonary function in a population sample of children. Am Rev Respir Dis 1980;122:697- 707. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992;326:862-866. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol 1996;97:742-748. World Health Organization (WHO). Epidemiology of chronic non-specific respiratory diseases. Bull WHO 1975;52:251-259. World Health Organization (WHO). Anatomical, Therapeutic, and Chemical index with defined daily doses (DDDs). Geneva: WHO Collaborating Center for Drug Statistics Methodology, 1997. Yang CY, Lin MC, Hwang KC. Childhood asthma and the indoor environment in a subtropical area. Chest 1998;114:393-397. Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997;350:85-90. Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child 1998;79:405-410. Yusoff NA, Hampton SM, Dickerson JW, Morgan JB. The effects of exclusion of dietary egg and milk in the management of asthmatic children: a pilot study. J R Soc Health 2004;124:74-80. Zoratti EM, Havstad S, Rodriguez J, Robens-Paradise Y, Lafata JE, McCarthy B. Health service use by African Americans and Caucasians with asthma in a managed care setting. Am J Respir Crit Care Med 1998;158:371-377. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35047 | - |
| dc.description.abstract | 研究目的：探討台灣氣喘門診處方型態及其與醫療照護利用的關係。
研究設計：回溯性研究分析。 研究對象：3,346位慢性氣喘患者，在2001年1月和2001年12月間至少有一次門診氣喘用藥處方。 主要結果測量：每一位氣喘病患經過一年的追蹤，有住院、急診和門診醫療照護利用氣喘病人的百分比。 研究結果：門診氣喘藥物治療的使用，仍以口服為主，約佔五分之四，且以β2-agonists和xanthine類為主。而吸入劑型的使用只佔五分之一，其中仍以吸入性β2-agonists為主，吸入性皮質類固醇次之。在氣喘相關門診醫療照護利用方面，僅用吸入劑氣喘用藥明顯的比僅用口服劑型（1 vs. 0.49）以及併用吸入劑和口服氣喘用藥（1 vs. 0.60）的多。而用藥數量方面，使用四種或四種以上氣喘用藥氣喘相關門診醫療照護利用明顯的比使用一種（1 vs. 0.50）或併用兩種氣喘用藥（1 vs. 0.67）要多。Charlson comorbidity index分數在1分以上的病患其氣喘相關門診利用明顯的比0分的多（3.69 vs. 1）。醫學中心氣喘相關門診利用明顯的比地區醫院（1 vs. 0.77）多。 結論：門診氣喘用藥以口服為主。氣喘門診處方型態只與氣喘相關門診醫療照護利用有關。僅用吸入性氣喘用藥的門診利用比僅用口服及吸入與口服併用的病患多，使用藥物數量在一種或兩種的病患，氣喘相關門診利用比四種或四種以上少。病患年齡在45-64歲，Charlson comorbidity index分數在1分以上，有較多氣喘相關門診醫療照護利用。地區醫院門診利用明顯比醫學中心少。 | zh_TW |
| dc.description.abstract | Objective: To investigate the relationship of the prescribing pattern of antiasthmatics to healthcare utilization in Taiwan.
Design: Retrospective study analysis. Setting: From 2000 to 2002 claim data from all contracted hospital of the Bureau of National Health Insurance, Taiwan. Subjects: 3,364 chronic asthma patients who received at least one outpatient prescription of antiasthmatic medication between January 2001 and December 2001. Main outcome measurements: Percentages of patients whose utilization of hospitalization, emergency room visits, and ambulatory care visits during the 12-month follow-up period. Results: Patients were prescribed with oral antiasthmatic agents more frequently than inhaled (approximately 80% vs. 20%). The prescribing pattern of antiasthmatics was only associated with ambulatory care visits for asthma. Compared with inhaled antiasthmatics alone, using oral alone and combination of inhaled and oral agents significantly decreased the likelihood of an asthma-related ambulatory care visit by 33% and 50%. Patients who taking one (1 vs. 0.50) or two (1 vs. 0.67) types of antiasthmatics had lower ambulatory care visits for asthma than those taking more than 4 types. Among patients who aged 45-64 years old had more ambulatory care visits for asthma than those did 0-18 years old (1 vs. 1.58). District hospitals had fewer asthma-related ambulatory care visits than medical centers (1 vs. 0.77). Conclusions: Asthma-related healthcare utilization, only ambulatory care visits was associated with the prescribing pattern of antiasthmatics. Patients with Charlson comorbidity index score greater than 1 incurred greater ambulatory care visits for asthma than did patients with zero. Medical centers had more asthma-related ambulatory care visits than district hospitals． | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T06:39:36Z (GMT). No. of bitstreams: 1 ntu-94-R90845103-1.pdf: 642682 bytes, checksum: fe89396e2f740989aa54a72861c0be85 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 中文摘要…………………………………………….......….…II
英文摘要…………………………………...….…….……..…III 誌謝……………………………………………..….…………IV 目錄…………………………………………………...………..V 圖表目錄………………………………………...……..……VIII 第一章 前言……………………………………………...…..1 第一節 研究背景與動機……………………………………..…. 1 第二節 研究重要性………….………………………………...…2 第三節 研究目的…………………………………………………3 第二章 文獻探討……………………………………....…….4 第一節 氣喘的定義及其危險因子………………………………4 第二節 氣喘的流行病學………………………………………..10 第三節 氣喘的藥物治療………………………………………..14 第四節 氣喘治療處方指標的相關實證研究…………………..27 第三章 研究方法……………………………...………...….32 第一節 研究架構………………………………………………..32 第二節 研究變項及其操作型定義……………………………..33 第三節 研究假說………………………………………………..35 第四節 研究設計與研究材料…………………………………..36 第五節 資料處理與統計分析…………………………………..39 第四章 研究結果………………………………………...…41 第一節 氣喘治療藥物的使用情形……………………………..41 第二節 氣喘患者基本特質描述………………………………..43 第三節 氣喘處方型態與醫療照護利用的相關情形…………..49 第五章 研究討論………………………………………..….72 第一節 研究討論………………………………………………..72 第二節 研究限制………………………………………………..75 第六章 結論與建議……………………………………..….76 第一節 結論……………………………………………………..76 第二節 建議………………………………………………….….77 參考文獻……………………………………………………...99 附錄一 各類型氣喘治療藥的ATC代碼.……..…..…..…..114 附錄二 Charlson Comorbidity Index與疾病種類、 ICD-9-CM對照表…………………...……….…...115 | |
| dc.language.iso | zh-TW | |
| dc.subject | 氣喘 | zh_TW |
| dc.subject | 醫療照護利用 | zh_TW |
| dc.subject | 處方型態 | zh_TW |
| dc.subject | rescribing pattern | en |
| dc.subject | asthma | en |
| dc.subject | healthcare utilization | en |
| dc.title | 氣喘處方型態與醫療照護利用的關係 | zh_TW |
| dc.title | Relationship of the prescribing pattern of antiasthmatics to healthcare utilization | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 黃文鴻,高雅慧 | |
| dc.subject.keyword | 氣喘,處方型態,醫療照護利用, | zh_TW |
| dc.subject.keyword | asthma,rescribing pattern,healthcare utilization, | en |
| dc.relation.page | 116 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-08-03 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 衛生政策與管理研究所 | zh_TW |
| Appears in Collections: | 健康政策與管理研究所 | |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ntu-94-1.pdf Restricted Access | 627.62 kB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.